Michel Lanteri-Minet
Institution: | Chu Nice, Hôpital Cimiez |
Country: | France |
Disclosures
Employment: Pain Department CHU Nice France, FHU InovPain Côte Azur University, France
Society Leadership/Board position: Past President-French Headache Society, French Pain Society
Personal fees: Abbvie/Allergan, Amgen, Boston Scientific, Grunenthal, Eli Lilly, Lundbeck, Medtronic, Novartis, Pfizer, ReckittBenckiser, Saint-Jude, Sanofi-Aventis, Teva, UPSA. Zambon
Research support: Eli Lilly, Medtronic, Novartis, Teva
Clinical trials involvement: Abbvie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, Teva
Relationship with scientific journals: Editorial Board member-Brain, Cephalalgia, Current Pain and Headache Reports, European Journal of Pain, European Neurological Journal, Headache, Journal of Headache and Pain, Journal Neurology Neurosurgery and Psychiatry, Journal of Psychosamatic Research, Lancet Neurology, Orphanet Journal Of Rare Diseases, Neurology